Does coasting, a procedure to avoid ovarian hyperstimulation syndrome, affect assisted reproduction cycle outcome?

Fertility and Sterility

Volumn 94, Issue 1, 2010, Pages 189-193

  Yilmaz, Nafiye ^a   Uygur, Dilek ^a   Ozgu, Emre ^a   Batioglu, Sertac ^a  

^a ZEKAI TAHIR BURAK WOMEN S HEALTH EDUCATION AND RESEARCH HOSPITAL   (Turkey)

Author keywords

Coasting; infertility; IVF; OHSS

Indexed keywords

CHORIONIC GONADOTROPIN; ESTRADIOL; GONADORELIN AGONIST; GONADOTROPIN; LEUPRORELIN; PROGESTERONE; RECOMBINANT FOLLITROPIN;

ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EMBRYO; ESTRADIOL BLOOD LEVEL; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; METAPHASE; NIDATION; OOCYTE RETRIEVAL; OVARY FOLLICLE; OVARY HYPERSTIMULATION; PATIENT SAFETY; PREGNANCY RATE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TREATMENT WITHDRAWAL;

ADULT; FEMALE; FERTILIZATION IN VITRO; GONADOTROPINS; HUMANS; OOCYTE RETRIEVAL; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; REPRODUCTION; REPRODUCTIVE TECHNIQUES, ASSISTED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77952541342     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2009.02.090     Document Type: Article

References (19)

1. Smitz J., Camus M., Devroey P., Erard P., Wisanto A., and Van Steirteghem A.C. Incidence of severe ovarian hyperstimulation syndrome after GnRH agonist/HMG superovulation for in-vitro fertilization. Hum Reprod 5 (1990) 933-937
2. Buvat J., Buvat-Herbaut M., Marcolin G., Dehaene J.L., Verbecq P., and Renouard O. Purified follicle-stimulating hormone in polycystic ovary syndrome: slow administration is safer and more effective. Fertil Steril 52 (1989) 553-559
3. Egbase P.E., Makhseed M., Al Sharhan M., and Grudzinskas J.G. Timed unilateral ovarian follicular aspiration prior to administration of human chorionic gonadotropin for the prevention of severe ovarian hyperstimulation syndrome in in-vitro fertilization: a prospective randomized study. Hum Reprod 12 (1997) 2603-2606
4. Amit A., Yaron Y., Yovel I., Peyser M.R., David M.P., Botchan A., et al. Repeated aspiration of ovarian follicles and early corpus luteum cysts in an in-vitro fertilization programme reduces the risk of ovarian hyperstimulation syndrome in high responders. Hum Reprod 8 (1993) 1184-1186
5. Shalev E., Giladi Y., Matilsky M., and Ben-Ami M. Decreased incidence of severe ovarian hyperstimulation syndrome in high risk in-vitro fertilization patients receiving intravenous albumin: a prospective study. Hum Reprod 10 (1995) 1373-1376
6. Fukaya T., Murakami T., Tamura M., Watanabe T., Terada Y., and Yajima A. Laser vaporization of the ovarian surface in polycystic ovary disease results in reduced ovarian hyperstimulation and improved pregnancy rates. Am J Obstet Gynecol 173 (1995) 119-125
7. Titinen A., Husa L.M., Tulppala M., Simberg N., and Seppälä M. The effect of cryo preservation in prevention of ovarian hyperstimulation syndrome. Br J Obstet Gynecol 102 (1995) 326-329
8. Chian R.C. In-vitro maturation of immature oocytes for infertile women with PCOS. Reprod Biomed Online 8 (2004) 547-552
9. Rabinovici J., Kushnir O., Shalev J., Goldenberg M., and Blankstein J. Rescue of menotrophin cycles prone to develop ovarian hyperstimulation. Br J Obstet Gynecol 94 (1987) 1098-1102
10. Urman B., Pride S.M., and Yuen B.H. Management of over stimulated gonadotropin cycles with a controlled drift period. Hum Reprod 7 (1992) 213-217
11. Ben-Nun I., Shulman A., Ghetler Y., Shilon M., Kaneti H., and Beyth Y. The significance of 17 beta-estradiol levels in highly responding women during ovulation induction in IVF treatment: its impact and prognostic value with respect to oocytes maturation and treatment outcome. J Assist Reprod Genet 10 (1993) 213-215
12. Simón C., Cano F., Valbuena D., Remohí J., and Pellicer A. Clinical evidence for a detrimental effect on uterine receptivity of high serum estradiol concentrations in high and normal responder patients. Hum Reprod 10 (1995) 2432-2437
13. Ulug U., Bahceci M., Erden H.F., Shalev E., and Ben-Shlomo I. The significance of coasting duration during ovarian stimulation for conception in assisted fertilization cycles. Hum Reprod 17 (2002) 310-313
14. Chen D., Burmeister L., Goldschlag D., and Rosenwaks Z. Ovarian hyperstimulation syndrome: strategies for prevention. Reprod Biomed Online 7 (2003) 43-49
15. Garcia J.E., Acosta A.A., Hsiu J.G., and Jones Jr. H.W. Advanced endometrial maturation after ovulation induction with human menopausal gonadotropin/human chorionic gonadotropin for in vitro fertilization. Fertil Steril 41 (1984) 31-35
16. Ben-Nun I., Jaffe R., Fejgin M.D., and Beyth Y. Therapeutic maturation of endometrium in vitro fertilization and embryo transfer. Fertil Steril 57 (1992) 953-962
17. Delvigne A., Kostyla K., Murillo D., Van Hoeck J., and Rozenberg S. Oocytes quality and IVF outcome after coasting to prevent ovarian hyperstimulation syndrome. Int J Fertil Womens Med 48 (2003) 25-31
18. Nardo L.G., Cheema P., Gelbaya T.A., Horne G., Fitzgerald C.T., Pease E.H., et al. The optimal length of 'coasting protocol' in women at risk of ovarian hyperstimulation syndrome undergoing in vitro fertilization. Human Fertility (Camb.) 9 (2006) 175-180
19. Moon H.S., Joo B.S., Moon S.E., Lee S.K., Kim K.S., and Koo J.S. Short coasting of 1 or 2 days by withholding both gonadotropin and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome. Fertil Steril 90 (2008) 2172